BB's Stock Haven

[Covid19freak]

UNCY $0.70 another hot biotech nearing final results for their kidney disease treatment expected in Q2 targeting $3 billion market while company´s valuation is only 24 million this one could run back to $2+ in the coming weeks ...

https://finance.yahoo.com/news/unicycive-therapeutics-announces-enrollment-first-120300532.html
“OLC’s novel characteristics have the potential to make it the best-in-class phosphate binder in the billion-dollar hyperphosphatemia market. Data from this pivotal trial is the last major component to complete our data package to file a New Drug Application (NDA) and will be informative for physicians as they consider a new potential therapy for their patients. We expect to report data from the trial in the second quarter of 2024 and file the NDA shortly thereafter.”